Erin Alison Blake, MD
Gynecological Oncology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 13 years
- University of Southern California Keck School of Medicine, 2013
Offices
1 location · California Cancer Associates for Research and Excellence Inc · 64 clinicians in this group
Hospitals listed: Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Blake’s office at (559) 326-1222 to ask if they take your plan before you enroll.
California Medical Board record
Licence A148612 · Current
Licensed to practise in California · since 2017 · expires 2028-05-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Gynecologic Oncology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$53,250
Medicare paid this office $53,250 for 95 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 34 | $5,732 | $169 |
| Long return visit (40+ min) | 22 | $3,820 | $147 |
| Return visit (30+ min) | 27 | $3,010 | $104 |
| Short return visit (20+ min) | 27 | $2,328 | $73 |
| Pelvic exam | 60 | $1,251 | $19 |
See all 9 services
| New patient visit (60+ min) | 34 | $5,732 | $169 |
| Long return visit (40+ min) | 22 | $3,820 | $147 |
| Return visit (30+ min) | 27 | $3,010 | $104 |
| Short return visit (20+ min) | 27 | $2,328 | $73 |
| Pelvic exam | 60 | $1,251 | $19 |
| Blood test, comprehensive group of blood chemicals | 34 | $404 | $10 |
| Insertion of needle into vein for collection of blood sample | 31 | $329 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 31 | $274 | $8 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 13 | $265 | $20 |
Procedures Medicare counted
| Removal of the uterus | 25 | More than 95% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
95 Original Medicare patients in 2024. Average age 70 · Women 100% · Also on Medicaid 47% · Health risk score 1.58. Above the middle of the specialty; the typical gynecological oncology clinician is at 1.53.
Conditions among them: High blood pressure 75% · Cancer 46% · Diabetes 44% · Chronic kidney disease 28% · Coronary heart disease 23% · Depression 23% · Heart failure 18% · COPD 16%.
The office billed $197,934, Medicare allowed $66,756 and paid $53,250; for 970 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 95 | 970 | 70 | 1.58 | $197,934 | $53,250 |
| 2023 | 72 | 246 | 72 | 1.41 | $78,710 | $31,522 |
| 2022 | 74 | 299 | 71 | 1.32 | $107,283 | $40,026 |
| 2021 | 67 | 210 | 70 | 1.42 | $80,646 | $32,895 |
| 2020 | 26 | 74 | 72 | 1.03 | $32,135 | $14,984 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Long return visit (40+ min) | 22 | $7,210 | $109 |
| Short return visit (20+ min) | 31 | $2,132 | $48 |
| Return visit (30+ min) | 18 | $1,689 | $77 |
2022: 4 services
| Long return visit (40+ min) | 21 | $8,179 | $106 |
| New patient visit (60+ min) | 19 | $2,733 | $144 |
| Return visit (30+ min) | 23 | $2,526 | $66 |
| Short return visit (20+ min) | 23 | $1,638 | $47 |
2021: 4 services
| New patient visit (60+ min) | 33 | $4,534 | $137 |
| Long return visit (40+ min) | 19 | $4,416 | $105 |
| Return visit (30+ min) | 15 | $2,048 | $73 |
| Short return visit (20+ min) | 15 | $830 | $46 |
2020: 1 service
| New patient visit (60+ min) | 11 | $1,498 | $136 |
Medicaid work
$1,363 in 2024
Medicaid paid $1,363 for 111 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (60+ min) | 26 | $1,026 |
| Return visit (30+ min) | 30 | $250 |
| PELVIC EXAMINATION | 43 | $46 |
| COMPREHENSIVE METABOLIC PANEL | 12 | $42 |
| 2024 | 111 | 4 | 18 | $1,363 |
Drugs they prescribed that Part D paid
$162,781
Pharmacies billed $162,781 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 26% of their Part D prescriptions (42 of 163) in 2024. Above the middle of the specialty; the typical gynecological oncology clinician is at 13%.
137 generic and fewer than 11 brand-name prescriptions · $162,781 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 16 | $215 | $13 |
| Ibuprofen | 30 | $71 | $2 |
| Oxycodone | 12 | $37 | $3 |
| Tramadol | 28 | $28 | $1 |
Year by year
| 2024 | 163 | 65 | 26% (42) | None | $162,781 |
| 2023 | 314 | 66 | 7% (22) | 17% | $554,482 |
| 2022 | 299 | 70 | 10% (30) | 10% | $123,988 |
| 2021 | 256 | 67 | 13% (33) | 16% | $65,666 |
| 2020 | 103 | 29 | 12% (12) | 18% | $106,363 |
| 2019 | 78 | 24 | 15% (12) | 24% | $115,944 |
| 2018 | 56 | 16 | None | None | $58,290 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Zejula | 12 | $200,418 | $16,701 |
| Eliquis | 13 | $6,547 | $504 |
| Prochlorperazine Maleate | 29 | $690 | $24 |
| Ondansetron | 24 | $370 | $15 |
| Lidocaine-Prilocaine | 15 | $209 | $14 |
| Olanzapine Odt | 16 | $197 | $12 |
| Gabapentin | 15 | $172 | $11 |
| Olanzapine | 18 | $92 | $5 |
| Ibuprofen | 15 | $55 | $4 |
| Tramadol | 11 | $15 | $1 |
2022: 9 drugs
| Xarelto | 12 | $7,436 | $620 |
| Megestrol Acetate | 13 | $668 | $51 |
| Prochlorperazine Maleate | 25 | $507 | $20 |
| Ondansetron | 20 | $420 | $21 |
| Dexamethasone | 14 | $308 | $22 |
| Olanzapine Odt | 13 | $170 | $13 |
| Olanzapine | 16 | $108 | $7 |
| Ibuprofen | 26 | $96 | $4 |
| Tramadol | 21 | $28 | $1 |
2021: 7 drugs
| Xarelto | 13 | $7,458 | $574 |
| Prochlorperazine Maleate | 28 | $577 | $21 |
| Ondansetron | 19 | $268 | $14 |
| Lidocaine-Prilocaine | 12 | $213 | $18 |
| Ibuprofen | 23 | $98 | $4 |
| Oxycodone | 12 | $71 | $6 |
| Tramadol | 14 | $14 | $1 |
2020: 1 drug
| Ibuprofen | 14 | $82 | $6 |
Money from drug and device companies
$213 in 2025
| 2025 | 5 | 8 | None | $213 |
| 2024 | 4 | 6 | None | $129 |
| 2023 | 1 | 1 | None | $13 |
| 2022 | 1 | 2 | None | $144 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SpringWorks Therapeutics | Ogsiveo | $116 | 4 payments
|
| Spectrum Pharmaceuticals | Rolvedon | $28 | 1 payment
|
| Ipsen Biopharmaceuticals | Onivyde | $26 | 1 payment
|
| Novartis Pharmaceuticals | Scemblix | $26 | 1 payment
|
| GlaxoSmithKline | Ojjaara | $18 | 1 payment
|
See all 8 published payments
| SpringWorks Therapeutics | Meals · 2025-11-08 | Ogsiveo | $34 |
| Novartis Pharmaceuticals | Meals · 2025-09-19 | Scemblix | $26 |
| SpringWorks Therapeutics | Meals · 2025-06-18 | Ogsiveo | $35 |
| GlaxoSmithKline | Meals · 2025-05-30 | Ojjaara | $18 |
| SpringWorks Therapeutics | Meals · 2025-04-09 | Ogsiveo | $27 |
| Ipsen Biopharmaceuticals | Meals · 2025-03-20 | Onivyde | $26 |
| SpringWorks Therapeutics | Meals · 2025-02-13 | Ogsiveo | $19 |
| Spectrum Pharmaceuticals | Meals · 2025-02-11 | Rolvedon | $28 |
See earlier years (2024, 2023, 2022)
2024: $129
| GlaxoSmithKline | Jemperli | $75 | 3 payments
|
| Smith+Nephew | Collagenase Santyl | $25 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $14 | 1 payment
|
| Abbvie | Elahere | $14 | 1 payment
|
2023: $13
| AstraZeneca Pharmaceuticals LP | Lynparza | $13 | 1 payment
|
2022: $144
| Genmab U.S. | Tivdak | $144 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1750624961
- Licence
- CA A148612, NM MD2020-0588California A148612: Current · expires 2028-05-31
- Trained
- University of Southern California Keck School of Medicine, 2013 · 13 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VX0201X (207VX0201X)
- Mailing address
- 104 Woodmont Blvd Ste 500, Nashville, TN, 37205
- NPI first listed
- 2013-04-05
- NPI last updated
- 2026-02-16
- NPI record certified
- 2026-02-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1125 E Spruce Ave Ste 103, Fresno, CA, 93720